Overview

A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology Patients

Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this research is to study the pharmacology (how the body handles this drug) of valacyclovir in children receiving treatment for cancer. This study will last approximately 7 days.
Phase:
Phase 2
Details
Lead Sponsor:
Baylor College of Medicine
Collaborator:
Texas Children's Hospital
Treatments:
Acyclovir
Valacyclovir